Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Midlife Changes in Alzheimer's Biomarkers May Predict Dementia

July 6, 2015 11:31 am | by Washington University School of Medicine | News | Comments

Studying brain scans and cerebrospinal fluid of healthy adults, scientists have shown that changes in key biomarkers of Alzheimer's disease during midlife may help identify those who will develop dementia years later, according to new research. Read more...


Vanda: Listing of New Hetlioz Patent in FDA Orange Book

July 6, 2015 11:15 am | News | Comments

Vanda Pharmaceuticals Inc. (Vanda) today announced that a Hetlioz patent, number 9,060,995 ('995 patent), is now listed in the U.S. Food and Drug Administration publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Read more..


Uncovering the Mechanism of Our Oldest Anesthetic

July 6, 2015 11:09 am | News | Comments

MIT researchers reveal brainwave changes in patients receiving nitrous oxide, or “laughing gas.” Read more...


Basic Beliefs About Atherosclerosis Overturned

July 6, 2015 10:59 am | by University of Virginia Health System | News | Comments

Doctors’ efforts to battle the dangerous atherosclerotic plaques that build up in our arteries and cause heart attacks and strokes are built on several false beliefs about the fundamental composition and formation of the plaques, new research from the University of Virginia School of Medicine shows. Read more..


Washington Woman's Measles Death is First in U.S. Since 2003

July 6, 2015 10:51 am | by Martha Bellisle, Associated Press | News | Comments

A woman killed by measles in Washington state had been vaccinated against the disease as a child but succumbed because she had a compromised immune system, a local health official told a TV station. Read more...


Allergan to Acquire Oculeve Dry Eye Disease Development Programs

July 6, 2015 8:34 am | News | Comments

The acquisition of Oculeve adds novel, complementary dry eye development programs to Allergan's current eye care research and development programs. Read more...


New Test Could Predict Arthritis Drug Failure in Patients

July 6, 2015 8:25 am | by University of Manchester | News | Comments

These findings could help better manage patients’ symptoms.


How St. Johns Wort Can Make You Sick

July 6, 2015 8:25 am | by University of Adelaide | News | Comments

St John’s Wort can produce the same adverse reactions as antidepressants. Read more...


Supercharging Stem Cells to Create New Therapies

July 6, 2015 8:25 am | by University of Adelaide | News | Comments

Researchers have discovered a new method for culturing stem cells which sees the highly therapeutic cells grow faster and stronger. Read more...


Thailand's Only Known MERS Patient is Virus-Free

July 6, 2015 8:24 am | by The Associated Press | News | Comments

The ministry said that five laboratory tests showed negative results for the disease, including most recently on Wednesday. Read more...


Liberia Works to Contain Ebola, Find Source of New Cases

July 6, 2015 8:24 am | by Carley Petesch and Jonathan Paye-Layleh, Associated Press | News | Comments

Liberia is working hard to contain Ebola and find the source of the latest infections of the deadly virus recorded this week. Read more...


Discovery Points to a New Path Toward a Universal Flu Vaccine

July 2, 2015 2:18 pm | by Rockefeller University | News | Comments

Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. Read more...


Study Could Lead to Vaccines and Treatment of Dengue Virus

July 2, 2015 2:08 pm | by Vanderbilt University Medical Center | News | Comments

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus. Read more...


FDA Clears Drug for Leading Form of Cystic Fibrosis

July 2, 2015 1:54 pm | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

The Food and Drug Administration cleared the twice-a-day pill from Vertex Pharmaceuticals for a variation of cystic fibrosis that affects about 8,500 people in the U.S. who are 12 years and older. The approval notice was posted to the agency's website Thursday. Read more...


ViiV Healthcare, Desano Will Allow Competitive Supply of Dolutegravir in China

July 2, 2015 1:23 pm | News | Comments

ViiV Healthcare and Desano Pharmaceuticals (Desano) today announced a strategic manufacturing agreement to enable production in China of dolutegravir. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.